Andrew joined Davies Collison Cave in 2012 as a Trainee Patent Attorney in the Biotechnology group based in the Brisbane Office. Andrew's experience and interests cover a variety of technologies including immunology, biochemistry, cell signalling and bioinformatics. In addition, he is currently studying for a Master of Intellectual Property at the University of Technology, Sydney.
Prior to commencing on a career as a patent attorney, Andrew completed his PhD research at Monash University within in the Faculty of Medicine and Health Sciences and the Australian Synchrotron. Andrew’s thesis focussed on T cell recognition of host antigens, with a view to creating novel therapies for combating autoimmune disorders, including cancer and graft rejection. His hard work resulted in several high-impact publications, including first-author articles published in Nature Immunology and Immunity. In light of his cutting-edge research, he was invited to present his PhD research at both international and national conferences. In recognition of his achievements Andrew was awarded The Anthony Koelmyer PhD Excellence Award, and the Merk-Millipore Award for Best Student Paper.
Andrew has a background in molecular biology and cell signalling, studying a Masters degree at the Wellcome Trust Biocentre, at the University of Dundee (Scotland). His thesis investigated the molecular biology and biophysics of integral cell metabolism pathways, which resulted in a first-author publication in the prestigious EMBO Journal.
He also holds a Bachelors degree (with honours) in biochemistry, specialising in bioinformatics, and still holds a keen interest in computational methods including virtual screening, molecular dynamics and data mining.